Search
for
Sort by
Research 961–990 of 1000+
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program
- Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients
- Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- The effect of ovine secreted soluble factors on human dermal papilla cell aggregation
- Iododerma in pregnancy secondary to iodinated multivitamins
- Diagnosis and treatments of hirsutism: where are we?
- Hirsutism: from Brazil to a place near you
- Occupational alopecia or alopecia areata?
- Management of male pattern hair loss.
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Alopecia Areata–Specific Patient-Reported Outcome Measures
- Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3
- 43018 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients
- Treatment of Alopecia in Children
- Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
- Global expression profile and global genome methylation signatures in male patients with androgenetic alopecia
- An overview of female pattern hair loss
- An update on the pathophysiology of female pattern hair loss
- Quality of Life in Australian Women with Female Pattern Hair Loss
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study